Securities Code: 002370 Securities Abbreviation: Asia-Pacific Pharmaceutical Announcement No.: 2026-036
Zhejiang Asia-Pacific Pharmaceutical Co., Ltd.
Announcement on the Purchase of Directors' and Senior Management Liability Insurance
The Company and all members of the Board of Directors guarantee the truthfulness, accuracy, and completeness of the information disclosed, and that there are no false records, misleading statements, or major omissions.
Zhejiang Asia-Pacific Pharmaceutical Co., Ltd. (hereinafter referred to as the "Company" or "Asia-Pacific Pharmaceutical") held the twelfth meeting of the eighth Board of Directors on April 23, 2026, and deliberated and passed the "Proposal on Purchasing Directors' and Senior Management Liability Insurance." To further improve the Company's risk management system, encourage directors and senior management to perform their duties fully, and protect the interests of the Company and shareholders, in accordance with the "Code of Corporate Governance for Listed Companies" and other relevant regulations, the Company plans to purchase liability insurance for the Company, all directors, and senior management. The specific details are hereby announced as follows:
I. Directors' and Senior Management Liability Insurance Plan
- Insured Party: Zhejiang Asia-Pacific Pharmaceutical Co., Ltd.
- Insured Persons: The Company and its directors, senior management, and other relevant responsible personnel (the specific scope to be determined in consultation with the insurance company).
- Insurance Liability Limit: Not exceeding RMB 50 million (including RMB 50 million; the specific amount shall be subject to the finally signed insurance contract).
- Total Premium: Not exceeding RMB 250,000 per year (the specific amount shall be subject to the finally signed insurance contract).
- Insurance Period: 12 months per term (the specific period shall be subject to the finally signed insurance contract; renewal or re-insurance may be carried out annually thereafter).